HomeCompareWUHN vs EPRT

WUHN vs EPRT: Dividend Comparison 2026

WUHN yields 666666.67% · EPRT yields 3.97%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 WUHN wins by $8.275235618773884e+34M in total portfolio value
10 years
WUHN
WUHN
● Live price
666666.67%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8.275235618773884e+34M
Annual income
$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00
Full WUHN calculator →
EPRT
EPRT
● Live price
3.97%
Share price
$30.36
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$64.3K
Annual income
$13,170.85
Full EPRT calculator →

Portfolio growth — WUHN vs EPRT

📍 WUHN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodWUHNEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, WUHN + EPRT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
WUHN pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

WUHN
Annual income on $10K today (after 15% tax)
$56,666,666.67/yr
After 10yr DRIP, annual income (after tax)
$70,318,753,614,835,575,000,000,000,000,000,000,000,000.00/yr
EPRT
Annual income on $10K today (after 15% tax)
$337.37/yr
After 10yr DRIP, annual income (after tax)
$11,195.22/yr
At 15% tax rate, WUHN beats the other by $70,318,753,614,835,575,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of WUHN + EPRT for your $10,000?

WUHN: 50%EPRT: 50%
100% EPRT50/50100% WUHN
Portfolio after 10yr
$4.137617809386942e+34M
Annual income
$41,363,972,714,609,160,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.97%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

WUHN
No analyst data
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+16.9% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

WUHN buys
0
EPRT buys
0
No recent congressional trades found for WUHN or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricWUHNEPRT
Forward yield666666.67%3.97%
Annual dividend / share$2.00$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%29%
Portfolio after 10y$8.275235618773884e+34M$64.3K
Annual income after 10y$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00$13,170.85
Total dividends collected$8.275075881065991e+34M$38.7K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: WUHN vs EPRT ($10,000, DRIP)

YearWUHN PortfolioWUHN Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$66,677,367$66,666,666.67$11,212$512.01+$66.67MWUHN
2$415,506,651,117$415,435,306,334.37$12,689$692.09+$415506.64MWUHN
3$2,419,908,598,386,268$2,419,464,006,269,573.00$14,521$944.30+$2419908598.37MWUHN
4$13,171,697,643,084,456,000$13,169,108,340,884,183,000.00$16,841$1,302.88+$13171697643084.44MWUHN
5$67,004,927,492,790,120,000,000$66,990,833,776,312,020,000,000.00$19,841$1,821.64+$67004927492790120.00MWUHN
6$318,562,277,003,514,840,000,000,000$318,490,581,731,097,560,000,000,000.00$23,818$2,587.47+$318562277003514871808.00MWUHN
7$1,415,484,168,853,553,000,000,000,000,000$1,415,143,307,217,159,200,000,000,000,000.00$29,230$3,744.65+$1.415484168853553e+24MWUHN
8$5,878,130,573,362,507,000,000,000,000,000,000$5,876,616,005,301,833,000,000,000,000,000,000.00$36,816$5,540.38+$5.878130573362507e+27MWUHN
9$22,813,793,009,840,743,000,000,000,000,000,000,000$22,807,503,410,127,248,000,000,000,000,000,000,000.00$47,806$8,413.17+$2.2813793009840744e+31MWUHN
10$82,752,356,187,738,840,000,000,000,000,000,000,000,000$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00$64,324$13,170.85+$8.275235618773884e+34MWUHN

WUHN vs EPRT: Complete Analysis 2026

WUHNStock

Wuhan General Group (China), Inc., through its subsidiaries, researches, develops, and commercializes a range of cannabidiol (CBD)-based products under the Dr. AnnaRx brand for pharmacies. It also focuses on exploring and developing other indications for psilocybin new therapies that will enable patients who suffer from mental illness. The company offers its products for medical applications, including cancer, mental disorders, chronic pain, and others. Wuhan General Group (China), Inc. is headquartered in Pointe-Claire, Canada.

Full WUHN Calculator →

EPRTREIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this WUHN vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

WUHN vs SCHDWUHN vs JEPIWUHN vs OWUHN vs KOWUHN vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.